ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Clinical trial NCT04561518 · RECRUITING
Trial details
- NCT number
- NCT04561518
- Sponsor
- Alnylam Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-11-23
- Primary completion
- 2033-12-31
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.